This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 December 2025 and includes updates on respiratory virus epidemiology, cholera, Marburg virus, Middle East respiratory syndrome coronavirus (MERS-CoV), avian influenza, and swine influenza.
Respiratory viruses are on the rise across the EU/EEA: circulation of influenza viruses and RSV is increasing in several countries, while SARS-CoV-2 circulation continues to decrease
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 December 2025 and includes updates on respiratory virus epidemiology, SARS-CoV-2 variants, mpox, leprosy, Marburg virus disease, dengue, and chikungunya.
A study published today shows how public health laboratories can become more resilient against future respiratory infectious diseases. The findings call for sustained capacity, better coordination and EU-level support.
The purpose of this study was to provide evidence on how to help public health laboratories be better prepared and more resilient to future public health challenges related to respiratory infectious diseases.
Influenza vaccine coverage remains below the WHO-recommended threshold for risk groups in most EU/EEA countries, while COVID-19 vaccine coverage is declining across most countries.
This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
A new modelling study from RespiCompass, the European respiratory disease modelling hub coordinated by ECDC, indicates that influenza and COVID-19 vaccination programmes markedly reduced hospitalisations among older adults across Europe in the 2024/25 season.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 December 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, measles, Middle East respiratory syndrome (MERS-CoV), West Nile virus, and Marburg virus disease (MVD).
Respiratory viruses are on the rise across the EU/EEA: influenza activity is increasing rapidly and circulating widely, RSV is slowly increasing, while SARS-CoV-2 circulation continues to decrease.